vs
AVIAT NETWORKS, INC.（AVNW）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是AVIAT NETWORKS, INC.的2.0倍（$219.9M vs $111.5M），AVIAT NETWORKS, INC.净利率更高（5.1% vs -1.0%，领先6.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -5.7%），AVIAT NETWORKS, INC.自由现金流更多（$22.5M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 0.3%）
Aviat Networks是全球领先的微波传输与回传解决方案供应商，为公共及私营通信运营商提供通信基础设施支撑，同时也面向企业客户提供相关产品与服务，助力客户构建稳定高效的通信网络。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
AVNW vs OFIX — 直观对比
营收规模更大
OFIX
是对方的2.0倍
$111.5M
营收增速更快
OFIX
高出7.7%
-5.7%
净利率更高
AVNW
高出6.1%
-1.0%
自由现金流更多
AVNW
多$5.7M
$16.8M
两年增速更快
OFIX
近两年复合增速
0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $111.5M | $219.9M |
| 净利润 | $5.7M | $-2.2M |
| 毛利率 | 32.4% | 71.1% |
| 营业利润率 | 6.5% | 0.2% |
| 净利率 | 5.1% | -1.0% |
| 营收同比 | -5.7% | 2.0% |
| 净利润同比 | 27.2% | 92.4% |
| 每股收益（稀释后） | $0.44 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNWOFIX
| Q4 25 | $111.5M | $219.9M | ||
| Q3 25 | $107.3M | $205.6M | ||
| Q2 25 | $115.3M | $203.1M | ||
| Q1 25 | $112.6M | $193.6M | ||
| Q4 24 | $118.2M | $215.7M | ||
| Q3 24 | $88.4M | $196.6M | ||
| Q2 24 | $116.7M | $198.6M | ||
| Q1 24 | $110.8M | $188.6M |
净利润AVNWOFIX
| Q4 25 | $5.7M | $-2.2M | ||
| Q3 25 | $162.0K | $-22.8M | ||
| Q2 25 | $5.2M | $-14.1M | ||
| Q1 25 | $3.5M | $-53.1M | ||
| Q4 24 | $4.5M | $-29.1M | ||
| Q3 24 | $-11.9M | $-27.4M | ||
| Q2 24 | $1.5M | $-33.4M | ||
| Q1 24 | $3.9M | $-36.0M |
毛利率AVNWOFIX
| Q4 25 | 32.4% | 71.1% | ||
| Q3 25 | 33.2% | 72.2% | ||
| Q2 25 | 34.2% | 68.7% | ||
| Q1 25 | 34.9% | 62.8% | ||
| Q4 24 | 34.6% | 69.0% | ||
| Q3 24 | 22.4% | 68.7% | ||
| Q2 24 | 35.3% | 67.8% | ||
| Q1 24 | 32.5% | 67.5% |
营业利润率AVNWOFIX
| Q4 25 | 6.5% | 0.2% | ||
| Q3 25 | 4.8% | -8.3% | ||
| Q2 25 | 7.7% | -7.9% | ||
| Q1 25 | 8.3% | -25.2% | ||
| Q4 24 | 6.7% | -5.3% | ||
| Q3 24 | -17.6% | -9.6% | ||
| Q2 24 | 4.7% | -12.5% | ||
| Q1 24 | 5.1% | -15.6% |
净利率AVNWOFIX
| Q4 25 | 5.1% | -1.0% | ||
| Q3 25 | 0.2% | -11.1% | ||
| Q2 25 | 4.5% | -6.9% | ||
| Q1 25 | 3.1% | -27.4% | ||
| Q4 24 | 3.8% | -13.5% | ||
| Q3 24 | -13.4% | -13.9% | ||
| Q2 24 | 1.3% | -16.8% | ||
| Q1 24 | 3.5% | -19.1% |
每股收益（稀释后）AVNWOFIX
| Q4 25 | $0.44 | $-0.05 | ||
| Q3 25 | $0.01 | $-0.57 | ||
| Q2 25 | $0.42 | $-0.36 | ||
| Q1 25 | $0.27 | $-1.35 | ||
| Q4 24 | $0.35 | $-0.76 | ||
| Q3 24 | $-0.94 | $-0.71 | ||
| Q2 24 | $0.11 | $-0.88 | ||
| Q1 24 | $0.30 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $86.5M | $82.0M |
| 总债务越低越好 | $105.4M | — |
| 股东权益账面价值 | $271.6M | $450.0M |
| 总资产 | $659.4M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.39× | — |
8季度趋势，按日历期对齐
现金及短期投资AVNWOFIX
| Q4 25 | $86.5M | $82.0M | ||
| Q3 25 | $64.8M | $62.9M | ||
| Q2 25 | $59.7M | $65.6M | ||
| Q1 25 | $49.4M | $58.0M | ||
| Q4 24 | $52.6M | $83.2M | ||
| Q3 24 | $51.0M | $30.1M | ||
| Q2 24 | $64.6M | $26.4M | ||
| Q1 24 | $59.2M | $27.0M |
总债务AVNWOFIX
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | $157.2M | ||
| Q2 25 | $87.6M | $157.0M | ||
| Q1 25 | $73.9M | $156.9M | ||
| Q4 24 | $74.9M | $157.0M | ||
| Q3 24 | $83.4M | $118.5M | ||
| Q2 24 | $48.4M | $118.0M | ||
| Q1 24 | $48.9M | $118.2M |
股东权益AVNWOFIX
| Q4 25 | $271.6M | $450.0M | ||
| Q3 25 | $263.6M | $442.5M | ||
| Q2 25 | $263.2M | $458.3M | ||
| Q1 25 | $256.1M | $458.3M | ||
| Q4 24 | $249.6M | $503.1M | ||
| Q3 24 | $247.1M | $525.9M | ||
| Q2 24 | $255.9M | $546.0M | ||
| Q1 24 | $256.0M | $570.3M |
总资产AVNWOFIX
| Q4 25 | $659.4M | $850.6M | ||
| Q3 25 | $643.3M | $832.6M | ||
| Q2 25 | $633.3M | $837.2M | ||
| Q1 25 | $628.3M | $823.1M | ||
| Q4 24 | $594.1M | $893.3M | ||
| Q3 24 | $590.9M | $867.9M | ||
| Q2 24 | $535.2M | $882.0M | ||
| Q1 24 | $490.3M | $906.0M |
负债/权益比AVNWOFIX
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | 0.36× | ||
| Q2 25 | 0.33× | 0.34× | ||
| Q1 25 | 0.29× | 0.34× | ||
| Q4 24 | 0.30× | 0.31× | ||
| Q3 24 | 0.34× | 0.23× | ||
| Q2 24 | 0.19× | 0.22× | ||
| Q1 24 | 0.19× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $22.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 20.2% | 7.6% |
| 资本支出强度资本支出/营收 | 1.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 4.18× | — |
| 过去12个月自由现金流最近4个季度 | $16.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流AVNWOFIX
| Q4 25 | $23.9M | $27.7M | ||
| Q3 25 | $-11.7M | $12.4M | ||
| Q2 25 | $10.5M | $11.6M | ||
| Q1 25 | $1.6M | $-18.4M | ||
| Q4 24 | $20.8M | $23.7M | ||
| Q3 24 | $-27.2M | $11.7M | ||
| Q2 24 | $8.3M | $9.0M | ||
| Q1 24 | $15.3M | $-18.6M |
自由现金流AVNWOFIX
| Q4 25 | $22.5M | $16.8M | ||
| Q3 25 | $-13.5M | $2.5M | ||
| Q2 25 | $8.2M | $4.5M | ||
| Q1 25 | $-1.2M | $-25.1M | ||
| Q4 24 | $18.3M | $15.2M | ||
| Q3 24 | $-32.6M | $6.3M | ||
| Q2 24 | $7.5M | $-360.0K | ||
| Q1 24 | $14.8M | $-29.1M |
自由现金流率AVNWOFIX
| Q4 25 | 20.2% | 7.6% | ||
| Q3 25 | -12.6% | 1.2% | ||
| Q2 25 | 7.1% | 2.2% | ||
| Q1 25 | -1.0% | -13.0% | ||
| Q4 24 | 15.5% | 7.0% | ||
| Q3 24 | -36.8% | 3.2% | ||
| Q2 24 | 6.4% | -0.2% | ||
| Q1 24 | 13.4% | -15.4% |
资本支出强度AVNWOFIX
| Q4 25 | 1.3% | 4.9% | ||
| Q3 25 | 1.6% | 4.8% | ||
| Q2 25 | 2.0% | 3.5% | ||
| Q1 25 | 2.5% | 3.5% | ||
| Q4 24 | 2.1% | 4.0% | ||
| Q3 24 | 6.1% | 2.7% | ||
| Q2 24 | 0.7% | 4.7% | ||
| Q1 24 | 0.4% | 5.6% |
现金转化率AVNWOFIX
| Q4 25 | 4.18× | — | ||
| Q3 25 | -72.48× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
